Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing (Q42951871)

11 November 2017

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing (English)

1 reference

11 November 2017

Suda T

1

1 reference

11 November 2017

Hashimoto H

2

1 reference

11 November 2017

Tanaka M

3

1 reference

11 November 2017

Ochi T

4

1 reference

11 November 2017

Nagata S

5

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

Journal of Experimental Medicine

11 November 2017

1 reference

11 November 2017

186

1 reference

11 November 2017

12

1 reference

11 November 2017

2045-2050

1 reference

Apoptosis by death factor

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

A major role for the Fas pathway in acute graft-versus-host disease.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Fas and Fas ligand: lpr and gld mutations

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Metalloproteinase-mediated release of human Fas ligand

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Expression and function of mouse Fas antigen on immature and mature T cells.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2199173

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

16 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1084%2FJEM.186.12.2045

Functional Consequences of APO-1/Fas (CD95) Antigen Expression by Normal and Neoplastic Hematopoietic Cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1084%2FJEM.186.12.2045

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1084%2FJEM.186.12.2045

Essential roles of the Fas ligand in the development of hepatitis

21 January 2018

1 reference

12 December 2020

Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro

1 reference

12 December 2020

DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement

1 reference

12 December 2020

Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness

1 reference

12 December 2020

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

12 December 2020

Fas ligand in human serum

1 reference

12 December 2020

Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis

1 reference

12 December 2020

Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand

1 reference

12 December 2020

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.186.12.2045

1 reference

11 November 2017

1 reference

11 November 2017

PubMed publication ID

9396774

1 reference